While considerable work has been carried out to understand the role of AR within HCC, additional work is needed to better understand the influence of AR-SVs on known oncogenic signaling in HCC, their potential for HCC-specific action as compared to PCa, and potentially distinct AR-SV and AR-FL genetic programs in HCC. This evidence concerns the gene AR and posterior cortical atrophy.